- Home
- ACHV vs LPTH Comparison
ACHV vs LPTH Comparison
Compare ACHV & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- LPTH
- Stock Information
- Founded
- ACHV N/A
- LPTH 1985
- Country
- ACHV Canada
- LPTH United States
- Employees
- ACHV N/A
- LPTH N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LPTH Semiconductors
- Sector
- ACHV Health Care
- LPTH Technology
- Exchange
- ACHV Nasdaq
- LPTH Nasdaq
- Market Cap
- ACHV 72.5M
- LPTH 81.1M
- IPO Year
- ACHV N/A
- LPTH 1996
- Fundamental
- Price
- ACHV $1.99
- LPTH $2.02
- Analyst Decision
- ACHV Strong Buy
- LPTH Strong Buy
- Analyst Count
- ACHV 3
- LPTH 3
- Target Price
- ACHV $14.33
- LPTH $4.67
- AVG Volume (30 Days)
- ACHV 193.4K
- LPTH 118.7K
- Earning Date
- ACHV 05-08-2025
- LPTH 05-08-2025
- Dividend Yield
- ACHV N/A
- LPTH N/A
- EPS Growth
- ACHV N/A
- LPTH N/A
- EPS
- ACHV N/A
- LPTH N/A
- Revenue
- ACHV N/A
- LPTH $32,158,517.00
- Revenue This Year
- ACHV N/A
- LPTH $16.90
- Revenue Next Year
- ACHV N/A
- LPTH $52.77
- P/E Ratio
- ACHV N/A
- LPTH N/A
- Revenue Growth
- ACHV N/A
- LPTH N/A
- 52 Week Low
- ACHV $1.84
- LPTH $1.04
- 52 Week High
- ACHV $5.59
- LPTH $4.42
- Technical
- Relative Strength Index (RSI)
- ACHV 31.53
- LPTH 49.64
- Support Level
- ACHV $1.98
- LPTH $1.61
- Resistance Level
- ACHV $2.28
- LPTH $1.93
- Average True Range (ATR)
- ACHV 0.24
- LPTH 0.19
- MACD
- ACHV -0.02
- LPTH 0.04
- Stochastic Oscillator
- ACHV 15.62
- LPTH 65.08
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.